396 related articles for article (PubMed ID: 29191959)
1. Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.
Perico N; Casiraghi F; Remuzzi G
J Am Soc Nephrol; 2018 Feb; 29(2):362-375. PubMed ID: 29191959
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.
Rota C; Morigi M; Cerullo D; Introna M; Colpani O; Corna D; Capelli C; Rabelink TJ; Leuning DG; Rottoli D; Benigni A; Zoja C; Remuzzi G
Stem Cell Res Ther; 2018 Aug; 9(1):220. PubMed ID: 30107860
[TBL] [Abstract][Full Text] [Related]
3. Progress toward the Clinical Application of Mesenchymal Stromal Cells and Other Disease-Modulating Regenerative Therapies: Examples from the Field of Nephrology.
Hickson LJ; Herrmann SM; McNicholas BA; Griffin MD
Kidney360; 2021 Mar; 2(3):542-557. PubMed ID: 34316720
[TBL] [Abstract][Full Text] [Related]
4. Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease.
Yun CW; Lee SH
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30939749
[TBL] [Abstract][Full Text] [Related]
5. Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models.
Zhao L; Han F; Wang J; Chen J
Stem Cell Res Ther; 2019 Dec; 10(1):385. PubMed ID: 31843011
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges.
Aghajani Nargesi A; Lerman LO; Eirin A
Stem Cell Res Ther; 2017 Dec; 8(1):273. PubMed ID: 29202871
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cells for tolerance induction in organ transplantation.
Casiraghi F; Perico N; Remuzzi G
Hum Immunol; 2018 May; 79(5):304-313. PubMed ID: 29288697
[TBL] [Abstract][Full Text] [Related]
8. Rationale of mesenchymal stem cell therapy in kidney injury.
Fleig SV; Humphreys BD
Nephron Clin Pract; 2014; 127(1-4):75-80. PubMed ID: 25343826
[TBL] [Abstract][Full Text] [Related]
9. Intra-renal arterial injection of autologous bone marrow mesenchymal stromal cells ameliorates cisplatin-induced acute kidney injury in a rhesus Macaque mulatta monkey model.
Moghadasali R; Azarnia M; Hajinasrollah M; Arghani H; Nassiri SM; Molazem M; Vosough A; Mohitmafi S; Najarasl M; Ajdari Z; Yazdi RS; Bagheri M; Ghanaati H; Rafiei B; Gheisari Y; Baharvand H; Aghdami N
Cytotherapy; 2014 Jun; 16(6):734-49. PubMed ID: 24801377
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells in transplantation rejection and tolerance.
English K; Wood KJ
Cold Spring Harb Perspect Med; 2013 May; 3(5):a015560. PubMed ID: 23637312
[TBL] [Abstract][Full Text] [Related]
11. [Update nephrology 2013].
Schmaderer C; Heemann U; Moog P
MMW Fortschr Med; 2013 May; 155(9):56-9; quiz 60-1. PubMed ID: 23951664
[No Abstract] [Full Text] [Related]
12. Mesenchymal Stem Cells in Kidney Repair.
Morigi M; Rota C; Remuzzi G
Methods Mol Biol; 2016; 1416():89-107. PubMed ID: 27236667
[TBL] [Abstract][Full Text] [Related]
13. Cell therapy for kidney injury: different options and mechanisms--mesenchymal and amniotic fluid stem cells.
Morigi M; De Coppi P
Nephron Exp Nephrol; 2014; 126(2):59. PubMed ID: 24854642
[TBL] [Abstract][Full Text] [Related]
14. Clinical translation of multipotent mesenchymal stromal cells in transplantation.
Leuning DG; Reinders ME; de Fijter JW; Rabelink TJ
Semin Nephrol; 2014 Jul; 34(4):351-64. PubMed ID: 25217264
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
Casiraghi F; Perico N; Cortinovis M; Remuzzi G
Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cell-based therapies for acute kidney injury: progress in the last decade.
Fazekas B; Griffin MD
Kidney Int; 2020 Jun; 97(6):1130-1140. PubMed ID: 32305128
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow-mesenchymal stromal cell infusion in patients with chronic kidney disease: A safety study with 18 months of follow-up.
Makhlough A; Shekarchian S; Moghadasali R; Einollahi B; Dastgheib M; Janbabaee G; Hosseini SE; Falah N; Abbasi F; Baharvand H; Aghdami N
Cytotherapy; 2018 May; 20(5):660-669. PubMed ID: 29580865
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials.
Pileggi A; Xu X; Tan J; Ricordi C
Curr Opin Organ Transplant; 2013 Dec; 18(6):672-81. PubMed ID: 24220050
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients.
Makhlough A; Shekarchian S; Moghadasali R; Einollahi B; Hosseini SE; Jaroughi N; Bolurieh T; Baharvand H; Aghdami N
Stem Cell Res Ther; 2017 May; 8(1):116. PubMed ID: 28535817
[TBL] [Abstract][Full Text] [Related]
20. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
Reinders ME; Fibbe WE; Rabelink TJ
Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
